Lilly's ads can continue after Novo challenge, judge rules

No­vo Nordisk has suf­fered an­oth­er set­back in its up­hill bat­tle against Eli Lil­ly in the boom­ing obe­si­ty drug mar­ket af­ter a US judge re­ject­ed its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.